SILO (Silo Pharma Inc.) Rega marang bathi mangsa ngarep

Logo grafis Silo Pharma (SILO)

Geopolitical instability and logistics disruptions are complicating international trials, which puts pressure on the credit profile of Silo Pharma, Inc. (SILO). The future P/E multiple of Silo Pharma, Inc. (SILO) is demonstrating a consolidation phase, where 0.00 forms the current metric value. Market capitalization relies on the licensing of Alzheimer's disease patents and the launch of mid-stage trials for depression drugs, creating a foundation for financial stability.

Kapitalisasi marang proyeksi bathi: Silo Pharma Inc. (SILO) kanggo 28.04.2023 - 15.11.2026

Rincian metrik lan analitis perusahaan Silo Pharma (SILO)

- indikator valuasi pasar bisnis:
Pambiji fundamental:SILO silopharma.com
Produk merek silopharma.com

For Silo Pharma, Inc., a developer of complex psychotherapeutic agents, the business's forward P/E reflects the company's market value relative to projected net income. This ratio assesses future capital efficiency, accounting for the impact of precision logistics and cold chain control on profitability, where low values may signal undervaluation and inflated values may indicate increased investment risks.